BAKER BROS. ADVISORS LP
84 holdingsFiling period: 2026-03-31Current AUM: $19.24Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | INCY | Incyte Corporation | 30.74M | $2.89B | $3.67B | 19.09% | +421 | 2026-03-31 |
| 2 | ONC | BeOne Medicines Ltd. | 8.80M | $2.61B | $2.78B | 14.45% | -- | 2026-03-31 |
| 3 | INSM | Insmed Incorporated | 7.42M | $1.21B | $731.7M | 3.80% | +828.4K | 2026-03-31 |
| 4 | MDGL | Madrigal Pharmaceuticals, Inc. | 2.14M | $1.12B | $1.00B | 5.20% | -- | 2026-03-31 |
| 5 | ACAD | ACADIA Pharmaceuticals Inc. | 42.90M | $954.9M | $1.11B | 5.77% | -- | 2026-03-31 |
| 6 | RVMD | Revolution Medicines, Inc. | 9.56M | $929.3M | $1.79B | 9.31% | +100.0K | 2026-03-31 |
| 7 | CELC | Celcuity Inc. | 7.92M | $903.5M | $683.8M | 3.55% | -- | 2026-03-31 |
| 8 | KOD | Kodiak Sciences Inc. | 19.92M | $759.3M | $828.2M | 4.30% | -- | 2026-03-31 |
| 9 | KYMR | Kymera Therapeutics, Inc. | 8.66M | $721.1M | $895.2M | 4.65% | -- | 2026-03-31 |
| 10 | SMMT | Summit Therapeutics Inc. | 36.39M | $690.0M | $473.8M | 2.46% | -- | 2026-03-31 |
| 11 | PRAX | Praxis Precision Medicines, Inc. | 1.75M | $564.9M | $539.7M | 2.80% | +626.7K | 2026-03-31 |
| 12 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.60M | $487.4M | $556.2M | 2.89% | -- | 2026-03-31 |
| 13 | — | Alkermes plc | 10.01M | $354.0M | $354.0M | 1.84% | -- | 2026-03-31 |
| 14 | GRAL | GRAIL, Inc. | 4.03M | $208.2M | $276.2M | 1.44% | +1.94M | 2026-03-31 |
| 15 | EWTX | Edgewise Therapeutics, Inc. | 6.58M | $207.1M | $252.7M | 1.31% | -- | 2026-03-31 |
| 16 | IONS | Ionis Pharmaceuticals, Inc. | 2.05M | $153.8M | $106.0M | 0.55% | +255.9K | 2026-03-31 |
| 17 | — | Kiniksa Pharmaceuticals International, plc | 2.83M | $136.1M | $136.1M | 0.71% | -- | 2026-03-31 |
| 18 | IMVT | Immunovant, Inc. | 5.46M | $135.6M | $210.8M | 1.10% | -- | 2026-03-31 |
| 19 | — | Roivant Sciences Ltd. | 4.87M | $134.8M | $134.8M | 0.70% | -687,294 | 2026-03-31 |
| 20 | IDYA | IDEAYA Biosciences, Inc. | 3.95M | $131.5M | $140.1M | 0.73% | +327.7K | 2026-03-31 |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.99M | $124.9M | $168.7M | 0.88% | -182,862 | 2026-03-31 |
| 22 | STOK | Stoke Therapeutics, Inc. | 3.34M | $108.6M | $96.3M | 0.50% | -- | 2026-03-31 |
| 23 | — | Immatics N.V. | 10.92M | $107.4M | $107.4M | 0.56% | -1,177,401 | 2026-03-31 |
| 24 | ABCL | AbCellera Biologics Inc. | 30.28M | $105.7M | $172.9M | 0.90% | +2.75M | 2026-03-31 |
| 25 | ABVX | Abivax S.A. | 875.8K | $97.5M | $109.4M | 0.57% | -- | 2026-03-31 |
← Scroll →
Page 1 of 4